Navigation Links
Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly
Date:5/25/2011

SAN DIEGO, May 26, 2011 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) ("Amylin" or "the Company") today announced that the United States District Court for the Southern District of California issued a temporary restraining order (TRO) against Eli Lilly and Company (NYSE: LLY) ("Lilly") relating to its litigation with respect to the Amylin / Lilly diabetes collaboration agreement.

The U.S. District Court restrained Lilly from proceeding with its plans to use the same sales force to sell both exenatide and Boehringer Ingelheim GmbH's competitive linagliptin.  The court also enjoined Lilly from disclosing any confidential information about exenatide to any of its sales representatives or employees participating in the marketing, promotion or sale of linagliptin.  

The complete order is being filed today on Amylin's Current Report on Form 8-K with the Securities and Exchange Commission.  

In 2002, Amylin entered an alliance with Lilly for the global development and commercialization of exenatide, a medicine indicated as a first line treatment for type 2 diabetes that is currently marketed as BYETTA® (exenatide) injection.  Exenatide is also the active ingredient in BYDUREON™ (exenatide extended-release for injectable suspension), a once-weekly version currently under review by the FDA.  

About BYETTA® (exenatide) injection

BYETTA was the first glucagon-like peptide-1 (GLP-1) receptor agonist to be approved by the FDA for the treatment of type 2 diabetes. BYETTA exhibits many of the same effects as the human incretin hormone GLP-1. GLP-1 improves blood sugar after food intake through multiple effects that work in concert on the stomach, liver, pancreas and brain.

BYETTA is an injectable prescription medi
'/>"/>

SOURCE Amylin Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
2. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
3. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
4. Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
5. Amylin Pharmaceuticals Reports Third Quarter Financial Results
6. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
7. Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
8. Amylin Pharmaceuticals to Webcast Year-End Financial Results
9. Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference
10. Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
11. Amylin Pharmaceuticals to Present at The Barclays Capital 2010 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... Research and Markets  has announced the addition of ... report to their offering. Intranasal drug delivery ... of drugs for the treatment of local diseases in ... non-allergic rhinitis and sinusitis. The nose is considered to ... systematic drug delivery. Continuous technological advancement ...
(Date:8/26/2014)... , Aug. 26, 2014   Quanta Aesthetic Lasers , ... North America , expands the offerings in their robust ... which is now available for shipping to medical spas, clinics, ... . The QuantaShape is manufactured in the Chianti ... General Project .  The device was previously sold as both ...
(Date:8/26/2014)...  When it comes to diabetes supplies, innovations are often ... happens to answer a real medical need. ... market, Timesulin shows how long it,s been since your ... or double insulin doses. Very easy to use, Timesulin ... insulin pen after an injection. There is no settings ...
Breaking Medicine Technology:Global Intranasal Drug Delivery Market 2014-2018: Key Vendors are Becton, Dickinson and Company, GlaxoSmithKline, Johnson & Johnson and Novartis 2Global Intranasal Drug Delivery Market 2014-2018: Key Vendors are Becton, Dickinson and Company, GlaxoSmithKline, Johnson & Johnson and Novartis 3Another Italian Beauty Joins the Quanta Aesthetic Lasers Lineup 2Montméd obtains reimbursement of Timesulin, the smart insulin pen timer cap, by major insurance companies in Canada 2
... Popular antidepressants taken with tamoxifen can increase the risk ... May 30 A new study found that taking ... of breast cancer recurrence in women taking both medications. ... work effectively.(Logo: http://www.newscom.com/cgi-bin/prnh/20090530/DC24767LOGO ) ...
... Abstract # 25670ORLANDO, Fla., May 29 ... has selected new breast cancer research conducted ... in Detroit for posting on ASCO,s Web ... promising new therapeutic target for aggressive hormone ...
Cached Medicine Technology:New Research Shows Antidepressants May Thwart Breast Cancer Treatment 2New Research Shows Antidepressants May Thwart Breast Cancer Treatment 3Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy 2Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy 3
(Date:8/27/2014)... StartX , a nonprofit technology accelerator ... a pioneering institute driving biotechnology innovation at the University ... laboratory customized for the needs of early stage medical ... lab space, named “StartX-QB3 Labs,” is the first research ... Care focused on developing entrepreneurs from academia to industry. ...
(Date:8/27/2014)... August 27, 2014 For the first ... face on plastic surgery when triple-board certified, Park Avenue ... figurative clay sculptures he has created from life – ... and artistry at a unique event on September 9, ... at 23 Warren Street. The “faces” who will be ...
(Date:8/27/2014)... Humility of Mary Health Partners will offer SlimDown, ... Center in Boardman beginning Sept. 2 and at St. ... , SlimDown teaches participants to manage their weight by ... and behavior. , Classes run from 5:30 to 6:30 ... Mondays at St. Joe’s at the Mall. , The ...
(Date:8/27/2014)... 27, 2014 Two of Woodland Hills’ ... Jivraj of the Anacapa Dental Art Institute, deal with serious ... complex oral surgery. , So patients can be reluctant to ... sores left from biting their lip or gums. , “The ... by the accidental bite,” Dr. Reshad said. “This canker or ...
(Date:8/27/2014)... A recent news article in the Richmond, ... “Five tips for relieving dry skin.” Sharon Kleyne, international ... Power of Water radio show describes the article’s five ... are seldom reported but which, Kleyne believes, are equally ... is Founder of Bio Logic Aqua Research, a global ...
Breaking Medicine News(10 mins):Health News:StartX & QB3 Launch Lab for Life Science and Medical Technology Entrepreneurs 2Health News:StartX & QB3 Launch Lab for Life Science and Medical Technology Entrepreneurs 3Health News:StartX & QB3 Launch Lab for Life Science and Medical Technology Entrepreneurs 4Health News:Presenting A Remarkable Fusion of Art, Fashion and Plastic Surgery 2Health News:Humility of Mary Health Partners Offers SlimDown Classes 2Health News:Two of Ventura’s Best Cosmetic Dentists Offer 5 Tips for Dealing with Frequent Tongue or Lip Biting 2Health News:Two of Ventura’s Best Cosmetic Dentists Offer 5 Tips for Dealing with Frequent Tongue or Lip Biting 3Health News:Two of Ventura’s Best Cosmetic Dentists Offer 5 Tips for Dealing with Frequent Tongue or Lip Biting 4Health News:Two of Ventura’s Best Cosmetic Dentists Offer 5 Tips for Dealing with Frequent Tongue or Lip Biting 5Health News:Water Advocate Sharon Kleyne Reports New Discoveries for Relief of Dry Dehydrated Skin 2Health News:Water Advocate Sharon Kleyne Reports New Discoveries for Relief of Dry Dehydrated Skin 3
... as a potential heart disease therapy, raising high-density lipoprotein ... protein may not be effective, a new study suggests. ... Center on Aging (USDA HNRCA) at Tufts University ... between low plasma cholesterol ester transfer protein (CETP) activity ...
... ... Intelligence Agency has requested documents from an investigative journalist, even though the writer had ... , ... 15, 2009 -- In a bizarre about-face, the secretive Central Intelligence Agency has requested ...
... ... ... -- The popularity and hype surrounding buttock augmentation and other large-volume body enhancing injections ... deadly trend, cautions the Physicians Coalition for Injectable Safety . Permanent fillers ...
... for inflammatory marker may spot people in need of ... -- People with normal levels of LDL (bad) cholesterol ... inflammation in order to identify those who may benefit ... of heart attack, stroke and death, say U.S. researchers. ...
... , , PALM ... Inc. (Pink Sheets: CTYX) announced today that it has ... Sheets (Pink Sheets Current Information). The higher move ... Information available. http://www.pinksheets.com/content/doc/ps/Disclosure/Guidelines/2.pdf , Connectyx President Ronn ...
... Dec. 15 At a time when Americans spend over ... Dr. Raymond Hall is theorizing a painful connection between conventional ... Pillo1 ( www.pillo1.com ) to address the problem. A ... Sleep Disorders Center showed that Pillo1 re-educates the body to ...
Cached Medicine News:Health News:Low cholesterol transfer protein activity associated with heart disease risk 2Health News:CIA Requests its Own Documents from Author 2Health News:CIA Requests its Own Documents from Author 3Health News:Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly 2Health News:Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly 3Health News:Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly 4Health News:Normal Cholesterol Doesn't Guarantee Healthy Heart 2Health News:Connectyx Attains 'Current Listing' Status on Pink Sheets Exchange 2Health News:Connectyx Attains 'Current Listing' Status on Pink Sheets Exchange 3Health News:Sleep Study Shows Pillo1 Re-Educates Body to Naturally Move Into Optimal Sleep Position and Increases REM Sleep by 21.3% 2
An immunochromatographic rapid test for the detection of Plasmodium falciparum in whole blood....
Malaria device / strip (2 line, PAN specific-pLDH)...
Malaria device / strip (3 line, P.f/P.v Ag Test-pLDH)...
High sensitive, specific one step immunochromatographic assay for human infectious disease...
Medicine Products: